Insider Analysis From Baker & McKenzie On Terminating Distribution Agreements In Indonesia
This article was originally published in PharmAsia News
Executive Summary
Indonesia represents a huge opportunity for Big Pharma, but deals with Indonesian distributors can be tricky if they are not managed properly, particularly when it comes time to terminate a distribution agreement.